Autoreactive T-cell receptor (Vβ/D/Jβ) sequences in diabetes are homologous to insulin, glucagon, the insulin receptor

Journal of Molecular Recognition

Volumn 22, Issue 3, 2009, Pages 177-187

  Root Bernsteina, Robert ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Autoimmunity; Complementarity; Diabetes insulin; Glucagon; Glucagon receptor; Insulin receptor; Mimicry; Self nonself; TCR

Indexed keywords

GLUCAGON; GLUCAGON RECEPTOR; INSULIN; INSULIN RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; AUTOIMMUNE HEPATITIS; CHEMISTRY; DIABETES MELLITUS; HUMAN; IMMUNOLOGY; MOLECULAR GENETICS; MOUSE; MYASTHENIA GRAVIS; NONOBESE DIABETIC MOUSE; RHEUMATOID ARTHRITIS; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; ARTHRITIS, RHEUMATOID; DIABETES MELLITUS; GLUCAGON; HEPATITIS, AUTOIMMUNE; HUMANS; INSULIN; MICE; MICE, INBRED NOD; MOLECULAR SEQUENCE DATA; MYASTHENIA GRAVIS; PEPTIDES; RECEPTOR, INSULIN; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, GLUCAGON; SEQUENCE HOMOLOGY, AMINO ACID;

MUS;

EID: 66249148391     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.930     Document Type: Article

References (39)

1. Adelman MK, Schluter SF, Robey IF, Marchalonis JJ. 2007. Natural and autoantibodies to human T-cell receptor Vbeta segments: potential roles in immunomodulation. Crit. Rev. Immunol. 27: 221-232.
2. Baker FJ, Lee M, Chien Y-H, Davis MM. 2002. Restricted islet-cell reactive T cell repertoire of early pancreatic islet infiltrates in NOD mice. Proc. Natl Acad. Sci. U.S.A. 99: 9374-9379 . (Pubitemid 34764621)
3. Buggy J, Rossomoando A, MacDougall M, Mierz D, Wunderligh D, Yoo-Warren H.,Warren H. 1996. Human glucagon receptor monoclonal antibodies: antagonism of glucagon action and use in receptor characterization. Horm. Metab. Res. 28: 215-219. (Pubitemid 26173486)
4. Candeias S, Katz J, Benoist C, Mathis D, Haskins K. 1991. Islet-specific T-cell clones from nonobese diabetic mice express heterogeneous T-cell receptors. Proc. Natl Acad. Sci. U.S.A. 88: 6167-6170. (Pubitemid 21914907)
5. Durinovic-Bello I, Steinle A, Ziegler AG, Schendel DJ. 1994. HLA-DQ-restricted, islet-specific T-cell clones of a type I diabetic patient. T-cell receptor sequence similarities to insulitis-inducing T-cells of nonobese diabetic mice. Diabetes 43: 1318-1325.
6. Fabry M, Schaefer E, Ellis L, Kojro E, Fahrenholz F, Brandenburg D. 1992. Detection of a new hormone contat site within the insulin receptor ectodomain by the use of a novel photoreactive insulin. J. Biol. Chem. 267: 8950-8956.
7. Fuchs U, von Dorsche HH, Ziegler M, Ambrosius H. 1988. Anti-glucagon insulitis and A-cell hyperplasia of pancreatic islets. Z. Mikrosk. Anat. Forsch. 102: 829-9832. (Pubitemid 19040766)
8. Galley KA, Danska JS. 1995. Per-islet infiltrates of young non-obese diabetic mice display restricted TCR beta-chain diversity. J. Immunol. 154: 2969-2982.
9. Gergely A, Koranyl L, Halmos T, Zsombok M, Perfly F, Csizer F, Salamon F, Tako J. 1973. Anti-glucagon antibodies in diabetes mellitus. Ann. Immunol. Hung. 17: 231-233.
10. Griffin A, Zhao CW, Wegmann KW, Hickley WF. 1995. Experimental autoimmune insulitis. Induction by T lymphocytes specific for a peptide of proinsulin. Am. J. Pathol. 147: 845-857.
11. Hall FC, Thomson K, Procter J, McMichael AJ, Wordsworth BP. TCRbeta spectratyping in RA: evidence of clonal expansions in peripheral blood lymphocytes. Ann. Rheum. Dis. 1998. 57: 319-322. (Pubitemid 28351102)
12. Huang X, Miller W. 1991. A time-efficient, linear-space local similarity algorithm. Adv. Appl. Math. 12: 337-357.
13. Jarchum I, Baker JC, Yamada T, Takaki T, Marron MP, Serreze DV, DiLorenzo TP. 2007. In vivo cytotoxicity of insulin-specific CD8 T-cells in HLA-A*0201 transgenic NOD mice. Diabetes 56: 2551-2560.
14. Kent SC, Chen Y, Bregoll L, Clemmings SM, Kenyon NS, Ricordi C, Hering BJ, Hafler DA. 2005. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 435: 224-228. (Pubitemid 40685950)
15. Lohr HF, Pingle S, Weyer S, Fritz T, Galle PR. 2003. Individual and common antigen-recognition sites of liver-derived T cells in patients with autoimmune hepatitis. Scand. J. Immunol. 57: 284-290. (Pubitemid 36408210)
16. McGuire KL, Holmes DS. 2005. Role of complementary proteins in autoimmunity. Trends Immunol. 26: 367-372.
17. Nakayama M, Abiru N, Moriyama H, Babaya N, Liu E, Miao D, Yu L, Wegmann DR, Hutton JC, Elliott JF, Eisenbarth GS. 2005. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435: 220-223. (Pubitemid 40685949)
18. Nakayama M, Beilke JN, Jasinski JM, Kobayashi M, Miao D, Li M, Coulombe MG, Liu E, Elliott JF, Gill RG, Eisenbarth GS. 2007. Priming and effector dependence on insulin B: 9-23 peptide in NOD islet autoimmunity. J. Clin. Inves. 117: 1835-1843. (Pubitemid 47036317)
19. Narendran P, Williams AJ, Elsegood K, Leech NJ, Dayan CM. 2003. Humoral and cellular immune responses to proinsulin in adults with newly diagnosed type 1 diabetes. Diabetes Metab. Res. Rev. 19: 52-59. (Pubitemid 36285374)
20. Pendergraft W.F.,Preston G.A.,Shah R.R.,Tropsha A.,Carater C.W. Jr,Jennette J.C.,Falk R.J. 2004. Autoimmunity is triggered by cPR-3 (105-201), a protein complementary to human autoantigen proteinase-3. Nat. Med. 10:72-79. (Pubitemid 38524701)
21. Pendergraft W.F.,Jennette J.C.,Ralk R.J.,Preston G.A. 2005. Autoantigen complementarity: A new theory implicating complementary proteins as initiators of autoimmune disease. J. Mol. Med. 83:12-25. (Pubitemid 40169492)
22. Pinkse GG, Tysma OH, Bergen CA, Kester MG, Ossendorp F, van Veelen PA, Keymeulen B, Pipeleers D, Drijfhout JW, Roep BO. 2005. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. Proc. Natl Acad. Sci. U.S.A. 102: 18425-18430. (Pubitemid 43011242)
23. Pinkse GG, Boitard C, Tree TI, Peakman M, Roep BO. 2006. HLA class I epitope discovery in type 1 diabetes: independent and reproducible identification of proinsulin epitopes of CD8 T cells-report of the IDS T Cell Workshop Committee. Ann. N. Y. Acad. Sci. 1079: 19-23.
24. Preston GA, Pendergraft WF 3rd, Falk RJ. 2005. New insights that link microbes with the generation of antineutrophil cytoplasmic autoantibodies: the theory of autoantigen complementarity. Curr. Opin. Nephrol. Hypertens. 14: 217-222. (Pubitemid 40685632)
25. Prigent SA, Stanley KK, Siddle K. 1990. Identification of epitopes on the human insulin receptor reacting with rabbit polyclonal sera and mouse monoclonal antibodies. J. Biol. Chem. 265: 9970-9977. (Pubitemid 20194350)
26. Root-Bernstein RS. 1991. Self, nonself, and the paradoxes of autoimmunity. In Organism and the Development of Self, Tauber AI. (ed.). Kluwer: Boston; 159-209.
27. Root-Bernstein RS. 2002. Molecular complementarity III. Molecular complementarity as the basis for peptide hormone evolution. A. bioinformatic case study of insulin, glucagon, and gastrin. J. Theor. Biol. 218: 71-84. (Pubitemid 35217568)
28. Root-Bernstein RS. 2005. Peptide self-aggregation and peptide complementarity as bases for the evolution of peptide receptors: a review. J. Molec. Recognit. 18: 40-49. (Pubitemid 40059569)
29. Root-Bernstein RS. 2007. Antigenic complementarity in the induction of autoimmunity: a general theory and review. Autoimmunity Rev. 6: 272-277. (Pubitemid 46533822)
30. Root-Bernstein RS, Couturier J. 2006. Antigenic complementarity in the origins of autoimmunity: A general theory illustrated with a case study of idiopathic thrombocytopenia purpura. Clin. Develop. Immunol. 13: 49-65.
31. Root-Bernstein RS, Dobbelstein C. 2001. Insulin binds to glucagon forming a complex that is hyper-antigenic and inducing complementary antibodies having an idiotype-antiidiotype relationship. Autoimmunity 33: 153-169. (Pubitemid 32674329)
32. Rudensky AY, Preston-Huriburt P, Hoag S-C, Balrow A, Janeway CA. 1991. Sequence analysis of peptides bound to MHC class II molecules. Nature 353: 622-627. (Pubitemid 21912570)
33. Schloot NC, Willemen S, Duinkerken G, de Vries RR, Roep BO. 1998. Cloned T cells from a recent onset IDDM patient reactive with insulin B-chain. J. Autoimmun. 11: 169-175. (Pubitemid 28273013)
34. Simone E, Daniel D, Schloot N, Gottlieb P, Babu S, Kawasaki E,Wegmann D, Eisenbarth GS. 1997. T cell receptor restriction of diabetogenic autoimmune NOD T cells. Proc. Natl Acad. Sci. U.S.A. 94: 2518-2521. (Pubitemid 27136907)
35. Tackenberg B, Kruth J, Bartholemaeus JE, Schlegel K, Oertel WH, Willcox N, Hemmer B, Sommer N. 2007. Clonal expansions of CD4 B helper T cells in autoimmune myasthenia gravis. Eur. J. Immunol. 37: 849-863. (Pubitemid 46916951)
36. Tikochinski Y, Elias D, Steeg C, Marus H, Kantorowitz M, Reshef T, Ablamunits V, Cohen IR, Friedmann A. 1999. A shared TCR CDR3 sequence in NOD mouse autoimmune diabetes. Int. Immunol. 11: 951-956. (Pubitemid 29276607)
37. Unson CG, Cypress AM, Wu CR, Goldsmith PK, Merrifield RB, Sakmar TP. 1996. Antibodies against specific extracellular epitopes of the glucagon receptor block glucagon binding. Proc. Natl Acad. Sci. U.S.A. 93: 310-315. (Pubitemid 26038149)
38. Yip CC. 1992. The insulin-binding domain of insulin receptor is encoded by exon 2 and 3. J. Cell. Biochem. 48: 19-25.
39. Yip CC, Grunfeld C, Goldfine ID. Identification and characterization of the ligand-binding domain of insulin receptor by the use of an antipeptide antiserum against amino acid sequence 241-251 of the alpha subunit. Biochemistry 1991. 30: 695-701.